On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

President Trump rescinded a Biden-era Executive Order that would have lowered the copays for some drugs to $2 for Medicare ...

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

For those with prescription drug costs, this can be particularly burdensome. Fortunately, Medicare's prescription drug law includes a provision to spread these costs throughout the year, making ...

Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...